My NCBISign In
Molecular discrimination of responders and nonresponders to anti-TNFalpha therapy in rheumatoid arthritis by etanercept
Dirk Koczan, Susanne Drynda, Michael Hecker, Andreas Drynda, Reinhard Guthke, Joern Kekow, Hans-Juergen Thiesen
Arthritis Res Ther. 2008; 10(3): R50. Published online 2008 May 2. doi: 10.1186/ar2419
PMCID:
PMC2483439
Abstract Full Text PDF–564K Supplementary Material

Is Cited by the Following 19 Articles in this Archive:

Validation Study of Existing Gene Expression Signatures for Anti-TNF Treatment in Patients with Rheumatoid Arthritis
Erik J. M. Toonen, Christian Gilissen, Barbara Franke, Wietske Kievit, Agnes M. Eijsbouts, Alfons A. den Broeder, Simon V. van Reijmersdal, Joris A. Veltman, Hans Scheffer, Timothy R. D. J. Radstake, Piet L. C. M. van Riel, Pilar Barrera, Marieke J. H. Coenen
PLoS One. 2012; 7(3): e33199. Published online 2012 March 21. doi: 10.1371/journal.pone.0033199
PMCID:
PMC3310059
Abstract Full Text PDF–165K Supplementary Material
Reassessment of Blood Gene Expression Markers for the Prognosis of Relapsing-Remitting Multiple Sclerosis
Michael Hecker, Brigitte Katrin Paap, Robert Hermann Goertsches, Ole Kandulski, Christian Fatum, Dirk Koczan, Hans-Peter Hartung, Hans-Juergen Thiesen, Uwe Klaus Zettl
PLoS One. 2011; 6(12): e29648. Published online 2011 December 27. doi: 10.1371/journal.pone.0029648
PMCID:
PMC3246503
Abstract Full Text PDF–268K Supplementary Material
TNFAIP3 Gene Polymorphisms Are Associated with Response to TNF Blockade in Psoriasis
Trilokraj Tejasvi, Philip E. Stuart, Vinod Chandran, John J. Voorhees, Dafna D. Gladman, Proton Rahman, James T. Elder, Rajan P. Nair
J Invest Dermatol. Author manuscript; available in PMC 2012 September 1.
Published in final edited form as: J Invest Dermatol. 2012 March; 132(3): 593–600. Published online 2011 November 24. doi: 10.1038/jid.2011.376
PMCID:
PMC3278539
Free in PMC on 2012/09/01
Discovery and mechanism of ustekinumab: A human monoclonal antibody targeting interleukin-12 and interleukin-23 for treatment of immune-mediated disorders
Jacqueline M Benson, David Peritt, Bernard J Scallon, George A Heavner, David J Shealy, Jill M Giles-Komar, Mary Ann Mascelli
MAbs. 2011 Nov-Dec; 3(6): 535–545. Published online 2011 November 1. doi: 10.4161/mabs.3.6.17815
PMCID:
PMC3242840
Free in PMC on 2012/11/01
Inflammatory Profile and Response to Anti-Tumor Necrosis Factor Therapy in Patients with Chronic Pulmonary Sarcoidosis
Matthew J. Loza, Carrie Brodmerkel, Roland M. Du Bois, Marc A. Judson, Ulrich Costabel, Marjolein Drent, Mani Kavuru, Susan Flavin, Kim Hung Lo, Elliot S. Barnathan, Robert P. Baughman
Clin Vaccine Immunol. 2011 June; 18(6): 931–939. doi: 10.1128/CVI.00337-10
PMCID:
PMC3122612
Abstract Full Text PDF–1.2M Supplementary Material
Advances in rheumatology: new targeted therapeutics
Paul P Tak, Joachim R Kalden
Arthritis Res Ther. 2011; 13(Suppl 1): S5. Published online 2011 May 25. doi: 10.1186/1478-6354-13-S1-S5
PMCID:
PMC3123966
Abstract Full Text PDF–327K
Treatment of rheumatoid arthritis with tumour necrosis factor inhibitors
Devesh Mewar, Anthony G Wilson
Br J Pharmacol. 2011 February; 162(4): 785–791. doi: 10.1111/j.1476-5381.2010.01099.x
PMCID:
PMC3042190
Abstract Full Text PDF–324K
Functional genomics and rheumatoid arthritis: where have we been and where should we go?
James N Jarvis, Mark Barton Frank
Genome Med. 2010; 2(7): 44. Published online 2010 July 28. doi: 10.1186/gm165
PMCID:
PMC2923736
Abstract Full Text PDF–260K
The Gene Expression Profile in the Synovium as a Predictor of the Clinical Response to Infliximab Treatment in Rheumatoid Arthritis
Johan Lindberg, Carla A. Wijbrandts, Lisa G. van Baarsen, Gustavo Nader, Lars Klareskog, Anca Catrina, Rogier Thurlings, Margriet Vervoordeldonk, Joakim Lundeberg, Paul P. Tak
PLoS One. 2010; 5(6): e11310. Published online 2010 June 25. doi: 10.1371/journal.pone.0011310
PMCID:
PMC2892481
Abstract Full Text PDF–366K Supplementary Material
Peripheral blood gene expression patterns discriminate among chronic inflammatory diseases and healthy controls and identify novel targets
Bertalan Mesko, Szilard Poliska1, Andrea Szegedi, Zoltan Szekanecz, Karoly Palatka, Maria Papp, Laszlo Nagy
BMC Med Genomics. 2010; 3: 15. Published online 2010 May 5. doi: 10.1186/1755-8794-3-15
PMCID:
PMC2874757
Abstract Full Text PDF–1.3M Supplementary Material
Personalized medicine in psoriasis: developing a genomic classifier to predict histological response to Alefacept
Mayte Suárez-Fariñas, Kejal R Shah, Asifa S Haider, James G Krueger, Michelle A Lowes
BMC Dermatol. 2010; 10: 1. Published online 2010 February 12. doi: 10.1186/1471-5945-10-1
PMCID:
PMC2831811
Abstract Full Text PDF–1.8M
Association between the response to TNF-antagonists and plasma type I interferon activity and interferon-beta/alpha ratios in rheumatoid arthritis patients: a post-hoc analysis of a predominantly Hispanic Cohort
Clio P. Mavragani, Dan T. La, William Stohl, Mary K. Crow
Arthritis Rheum. Author manuscript; available in PMC 2011 February 1.
Published in final edited form as: Arthritis Rheum. 2010 February; 62(2): 392. doi: 10.1002/art.27226
PMCID:
PMC2821991
Abstract Full Text PDF–539K
Effective treatment of psoriasis with etanercept is linked to suppression of IL-17 signaling, not “immediate-response” TNF genes
Lisa C. Zaba, Mayte Suárez-Fariñas, Judilyn Fuentes-Duculan, Kristine Nograles, Emma Guttman-Yassky, Irma Cardinale, Michelle A. Lowes, James G. Krueger
J Allergy Clin Immunol. Author manuscript; available in PMC 2010 November 1.
Published in final edited form as: J Allergy Clin Immunol. 2009 November; 124(5): 1022–10.e1-395. doi: 10.1016/j.jaci.2009.08.046
PMCID:
PMC2852188
Abstract Full Text PDF–1.2M Supplementary Material
Integrative modeling of transcriptional regulation in response to antirheumatic therapy
Michael Hecker, Robert Hermann Goertsches, Robby Engelmann, Hans-Juergen Thiesen, Reinhard Guthke
BMC Bioinformatics. 2009; 10: 262. Published online 2009 August 24. doi: 10.1186/1471-2105-10-262
PMCID:
PMC2757030
Abstract Full Text PDF–1.5M Supplementary Material
Predicting the future of anti-tumor necrosis factor therapy
Cornelis L Verweij
Arthritis Res Ther. 2009; 11(3): 115. Published online 2009 June 22. doi: 10.1186/ar2724
PMCID:
PMC2714140
Abstract Full Text PDF–45K
Differential gene expression in the salivary gland during development and onset of xerostomia in Sjögren's syndrome-like disease of the C57BL/6.NOD-Aec1Aec2 mouse
Cuong Q Nguyen, Ashok Sharma, Byung Ha Lee, Jin-Xiong She, Richard A McIndoe, Ammon B Peck
Arthritis Res Ther. 2009; 11(2): R56. Published online 2009 April 20. doi: 10.1186/ar2676
PMCID:
PMC2688207
Abstract Full Text PDF–2.0M Supplementary Material
Rapid Myeloid Cell Transcriptional and Proteomic Responses to Periodontopathogenic Porphyromonas gingivalis
Salvador Nares, Niki M. Moutsopoulos, Nikola Angelov, Zoila G. Rangel, Peter J. Munson, Neha Sinha, Sharon M. Wahl
Am J Pathol. 2009 April; 174(4): 1400–1414. doi: 10.2353/ajpath.2009.080677
PMCID:
PMC2671371
Abstract Full Text PDF–3.6M Supplementary Material
Transcription profiling of rheumatic diseases
Lisa GM van Baarsen, Carina L Bos, Tineke CTM van der Pouw Kraan, Cornelis L Verweij
Arthritis Res Ther. 2009; 11(1): 207. Published online 2009 January 30. doi: 10.1186/ar2557
PMCID:
PMC2688218
Abstract Full Text PDF–866K
Differential Gene Expressions in the Lacrimal Gland During Development and Onset of Keratoconjunctivitis Sicca in Sjögren's Syndrome (SjS)-Like Disease of the C57BL/6.Nod-Aec1aec2 Mouse
Cuong Q. Nguyen, Ashok Sharma, Jin-Xiong She, Richard A. McIndoe, Ammon B. Peck
Exp Eye Res. Author manuscript; available in PMC 2010 March 1.
Published in final edited form as: Exp Eye Res. 2009 March; 88(3): 398–409. Published online 2008 October 18. doi: 10.1016/j.exer.2008.10.006
PMCID:
PMC2699904
Abstract Full Text PDF–1.7M
You are here: NCBI > Literature > PubMed Central (PMC)
Write to the Help Desk